PRETECH: a new point-of-care blood test to detect preeclampsia early and improve pregnancy care

Preeclampsia Test for Efficient Clinical Handling

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN31137599

Enrollment

150

Registered

2025-02-18

Start date

2025-03-01

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preeclampsia Pregnancy and Childbirth

Interventions

One enrolment consists of two blood samples (capillary from the finger and venous) taken from the participant during a routine pregnancy check-up at the Kantonsspital Baden hospital. This is where the

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Signed informed consent 2. Pregnant woman = 18 years of age 3. Gestational age > 11 weeks +0 days

Exclusion criteria

Exclusion criteria: Patients who have received heparin within 24 hours of enrolment.

Design outcomes

Primary

Measure	Time frame
Assay test results from Specimens A (whole blood from a fingerstick), B (EDTA tube), and C (serum) from venous blood sampling at 12, 20 and 36 weeks of gestation	—

Secondary

Measure	Time frame
Usability of préXclude Alpha measured using feedback from the investigative staff on the usability of the préXclude Alpha test throughout the study	—

Countries

Switzerland

Contacts

Public ContactMathias Wipf

mathias.wipf@mommdiagnostics.com+41 (0)79 681 65 32

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026